Healthtech Investors & VC Firms
3405 firms in this list, with a median first check of $500K. 736 of them lead rounds. Generated from verified public data and updated continuously.
Seae Ventures
MiamiPre-Seed–Series A
22 people
Softbank Latin America Fund
MiamiSeed–Growth
10 people
Leonard Green
Los AngelesGrowth–Late Stage
Amulet Capital Partners, LP
Greenwich
32 people
Sanderling Ventures
San MateoSeed–Late Stage$50K – $1M
8 people
Arkin Capital
HerzliyaSeed–Late Stage
28 people
Elevar Equity
BengaluruPre-Seed–Late Stage$1M – $10M
19 people
Kennet Partners
LondonSeries B–Late Stage$8.6M – $32.4M
19 people
New Capital Partners
BirminghamSeed–Growth$5M – $100M
10 people
Save the Children Global Ventures
Series A–Growth$150K – $500K
25 people
IAN Group
New DelhiPre-Seed–Series A$73K – $5M
27 people
Verlinvest
BrusselsSeed–Late Stage
18 people
BeiGene
ChangpingSeries A–Series B
38 people
Corewell Health Ventures
Grand RapidsSeries B–Late Stage
5 people
Human Ventures
New YorkPre-Seed–Series A$250K – $500K
8 people
Cedar Mundi Ventures
LondonPre-Seed–Late Stage$50K – $65M
10 people
Rabo Corporate Venturing
UtrechtSeed–Growth$11M – $27M
28 people
Deep Science Ventures
LondonPre-Seed–Seed
18 people
Juvo Ventures
Salt Lake CityPre-Seed–Series A$10K – $300K
21 people
LAV
Hong KongSeed–Series C$5M – $15M
3 people
Apollo Health Ventures
BerlinSeed–Series A
29 people
Beyond Capital Partners
Frankfurt am MainGrowth–Late Stage
23 people
SteelSky Ventures
AtlantaSeed$100K – $5M
11 people
TechVision Fonds
AachenPre-Seed–Series A$500K – $2M
20 people
Related lists
Investors & VC Firms in North America (13799)Investors & VC Firms in United States (12941)Investors & VC Firms in Europe (5510)Crypto & Web3 Investors & VC Firms (4813)Investors & VC Firms in Global (4133)SaaS Investors & VC Firms (3860)AI & Machine Learning Investors & VC Firms (3763)Fintech Investors & VC Firms (3709)Investors & VC Firms in Asia-Pacific (3560)Enterprise Software Investors & VC Firms (3215)
Data sourced from public filings and firms' own websites — see our methodology.

































































































